Rapid detection kit, ribonucleic acid detection reagent, medical syringes, medical mask, medical ventilator, medical glove, medical isolation gown, surgical gown level 3+4, protective gown (overall ), oximeter, other medical products.
Antigens, antibodies, uncut sheets, and finished ivd test kits.
HCV Rapid Hepatitis C Virus Test (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of antibody to Hepatitis C Virus in whole blood, serum or plasma. It is for professional in vitro diagnostic use only
Fast results Easy visually interpretation Simple operation, no equipment required High accuracy The Cardiac Troponin I Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of human cardiac Troponin I in whole blood, serum or plasma as an aid in the diagnosis of myocardial infarction (MI).
Corona Antigen Rapid Test Kits USD 4.85 FOB.
Hcg rapid diagnostics test kits(ce & iso)
HCV rapid diagnostics test kits(ce & iso)
Rapid antigen test kit for detection of COVID-19 . Easy,safe and accurate
European CE Certified 15 Minutes Detection Time Format 25T/Kit Colloidal Gold Method Detection Substance: Antibody Type of Sample : Serum/Plasma/Whole Blood No instruments needed
Cat.No - TO-CO-E0006 Size - 50T Price - 20475
Cat.No - TO-CO-E0008 Size - 50T Price - 20475
Cat.No - TO-CO-E0007 Size - 50T Price - 20475
Cat.No - TO-CO-E0010 Size - 50T Price - 20475
Cat.No - DR-CO-E0011 Size - 50T Price - 20475
Cat.No - DR-CO-E0009 Size - 50T Price - 20475
Cat.No - DR-CO-E0010 Size - 50T Price - 20475
Cat.No - DR-CO-E0008 Size - 50T Price - 20475
PC-PASS Protein Characterization Analysis Protein Characterization (Physicochemical property of proteins) structure analysis using mass spectrometry provides results that meet the requirements of the FDA, the MFDS and other regulatory authorities regarding novel therapies or biosimilars. Based on basic amino acid analysis (full sequencing), we perform post-translational modification (PTM) analysis, which is important for protein potency and stability. In this regard, we can perform test methods based on design of experiment (DOE) statistical methodology and deliver documents to be submitted to regulatory authorities. Protein identification and quantification : Structural analysis of all types of protein therapeutics, including monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), and enzymes - Full Length-Amino acids sequencing Peptide identification of each peak through peptide mapping (MS spectrum confirmation, MS/MS spectral analysis with 100% AA matches) - Improved N- and C-terminal sequencing of proteins Post-translational modification (PTM) : More reliable results based on design of experiment (DOE) statistical methodology to perform the experiments systematically and analyze data efficiently - Disulfide bond analysis ID Total possible lankage analysis - Deamidation identification and quantification - Phosphorylation identification and quantification , phospho-proteomic analysis - Other functional modifications Glycomics : Single protein analysis and research of protein complexes with glycosylation closely related to biological function and toxicity as well as structural stability of proteins - Glycosylation site determination - Glycan profiling - Site-specific glycan identification and quantification - Glycomics research with glycan enrichment
Biomarker Diseases Diagnosis Blood Tests Proteomics-based early diagnosis Provides a quick and accurate solution for early diagnosis of major diseases by utilizing multiple proteomic biomarker-based blood tests. Advantages of proteomics-based early diagnosis: Proteomics-based early diagnosis determines the presence of disease by identifying proteins that are specifically expressed in diseases and using these as biomarkers to measure the quantitative values of the relevant proteins in blood. Proteomics analysis has been assessed as highly likely to be used as a universal primary screening method because analysis can be performed even with trace samples, such as a few drops of blood.
Proteomics-based Early diagnosis using multiple markers provides a quick and accurate solution for early diagnosis of major diseases by utilizing multiple proteomic biomarker-based blood tests. Early diagnostic solutions BERTIS has commercialized MASTOCHECK, the worlds first proteomics-based blood test solution for early diagnosis of breast cancer, and clinical trials are being conducted on biomarkers for various cancers. Ultimately, these technologies are being used to continually expand the pipeline to allow dozens of diseases to be diagnosed with a single blood test.
